These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 39234647)

  • 1. Storyteller in ADNI4: Application of an early Alzheimer's disease screening tool using brief, remote, and speech-based testing.
    Skirrow C; Meepegama U; Weston J; Miller MJ; Nosheny RL; Albala B; Weiner MW; Fristed E;
    Alzheimers Dement; 2024 Oct; 20(10):7248-7262. PubMed ID: 39234647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ADNI4 Digital Study: A novel approach to recruitment, screening, and assessment of participants for AD clinical research.
    Miller MJ; Diaz A; Conti C; Albala B; Flenniken D; Fockler J; Kwang W; Sacrey DT; Ashford MT; Skirrow C; Weston J; Fristed E; Farias ST; Korecka M; Wan Y; Aisen PS; Beckett L; Harvey D; Lee EB; Petersen RC; Shaw LM; Okonkwo OC; Mindt MR; Weiner MW; Nosheny RL;
    Alzheimers Dement; 2024 Oct; 20(10):7232-7247. PubMed ID: 39219153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a Remote and Fully Automated Story Recall Task to Assess for Early Cognitive Impairment in Older Adults: Longitudinal Case-Control Observational Study.
    Skirrow C; Meszaros M; Meepegama U; Lenain R; Papp KV; Weston J; Fristed E
    JMIR Aging; 2022 Sep; 5(3):e37090. PubMed ID: 36178715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4.
    Weiner MW; Veitch DP; Miller MJ; Aisen PS; Albala B; Beckett LA; Green RC; Harvey D; Jack CR; Jagust W; Landau SM; Morris JC; Nosheny R; Okonkwo OC; Perrin RJ; Petersen RC; Rivera-Mindt M; Saykin AJ; Shaw LM; Toga AW; Tosun D; Trojanowski JQ;
    Alzheimers Dement; 2023 Jan; 19(1):307-317. PubMed ID: 36209495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Alzheimer's disease progression within 6 years using speech: A novel approach leveraging language models.
    Amini S; Hao B; Yang J; Karjadi C; Kolachalama VB; Au R; Paschalidis IC
    Alzheimers Dement; 2024 Aug; 20(8):5262-5270. PubMed ID: 38924662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leveraging speech and artificial intelligence to screen for early Alzheimer's disease and amyloid beta positivity.
    Fristed E; Skirrow C; Meszaros M; Lenain R; Meepegama U; Papp KV; Ropacki M; Weston J
    Brain Commun; 2022; 4(5):fcac231. PubMed ID: 36381988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological Equivalence of the Clinical Diagnosis of Mild Cognitive Impairment in the National Alzheimer's Coordinating Center Uniform Data Set and Alzheimer's Disease Neuroimaging Initiative.
    Kiselica AM; Benge JF;
    Dement Geriatr Cogn Disord; 2021; 50(3):231-236. PubMed ID: 34186536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A remote speech-based AI system to screen for early Alzheimer's disease via smartphones.
    Fristed E; Skirrow C; Meszaros M; Lenain R; Meepegama U; Cappa S; Aarsland D; Weston J
    Alzheimers Dement (Amst); 2022; 14(1):e12366. PubMed ID: 36348974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening over Speech in Unselected Populations for Clinical Trials in AD (PROSPECT-AD): Study Design and Protocol.
    König A; Linz N; Baykara E; Tröger J; Ritchie C; Saunders S; Teipel S; Köhler S; Sánchez-Benavides G; Grau-Rivera O; Gispert JD; Palmqvist S; Tideman P; Hansson O
    J Prev Alzheimers Dis; 2023; 10(2):314-321. PubMed ID: 36946458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
    Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
    Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling the sound of the cognitive status: Machine Learning-based speech analysis in the Alzheimer's disease spectrum.
    García-Gutiérrez F; Alegret M; Marquié M; Muñoz N; Ortega G; Cano A; De Rojas I; García-González P; Olivé C; Puerta R; García-Sanchez A; Capdevila-Bayo M; Montrreal L; Pytel V; Rosende-Roca M; Zaldua C; Gabirondo P; Tárraga L; Ruiz A; Boada M; Valero S
    Alzheimers Res Ther; 2024 Feb; 16(1):26. PubMed ID: 38308366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting progression from mild cognitive impairment to Alzheimer's disease on an individual subject basis by applying the CARE index across different independent cohorts.
    Chen J; Chen G; Shu H; Chen G; Ward BD; Wang Z; Liu D; Antuono PG; Li SJ; Zhang Z;
    Aging (Albany NY); 2019 Apr; 11(8):2185-2201. PubMed ID: 31078129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer-Assisted Speech Analysis in Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Study from Shanghai, China.
    Qiao Y; Xie XY; Lin GZ; Zou Y; Chen SD; Ren RJ; Wang G
    J Alzheimers Dis; 2020; 75(1):211-221. PubMed ID: 32250297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proper names from story recall are associated with beta-amyloid in cognitively unimpaired adults at risk for Alzheimer's disease.
    Mueller KD; Koscik RL; Du L; Bruno D; Jonaitis EM; Koscik AZ; Christian BT; Betthauser TJ; Chin NA; Hermann BP; Johnson SC
    Cortex; 2020 Oct; 131():137-150. PubMed ID: 32861209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
    J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting conversion of patients with Mild Cognitive Impairment to Alzheimer's disease using bedside cognitive assessments.
    Clarke A; Ashe C; Jenkinson J; Rowe O; A D N I ; Hyland P; Commins S
    J Clin Exp Neuropsychol; 2022 Dec; 44(10):703-712. PubMed ID: 36803664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of Cognitive Impairment Compatible with Early Diagnosis of Alzheimer's Disease. A Bayesian Network Model based on the Analysis of Oral Definitions of Semantic Categories.
    Guerrero JM; Martínez-Tomás R; Rincón M; Peraita H
    Methods Inf Med; 2016; 55(1):42-9. PubMed ID: 25925692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.